Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
To the Editor: Dr Shelton and colleagues1 concluded that "St John's wort was not effective
for treatment of major depression." These authors may have been overly skeptical
in interpreting their data. In the intent-to-treat analysis, according to
the study's response criterion, 26.5% of subjects receiving St John's wort
vs 18.6% of patients in the placebo group responded to treatment (P = .15), and according to the study's remission criterion, 14.3% vs
4.9% showed remission (P = .02). If one evaluates
this trial in the context of other similar studies, it is noteworthy that
the comparisons of St John's wort vs placebo in this study is in the same
direction as studies with a positive outcome, although it does not reach statistical
significance. What is surprising about these data is the low response rate
to placebo. A placebo response of 20% to 30% is routine in studies of depression.2 Thus, an equally reasonable conclusion is that
St John's wort was perhaps better than placebo in the treatment of major depression.
A third arm with an established antidepressant might have resolved these difficulties.
Brenner R, Madhusoodanan S, Pawlowska M, Czobor P. St John's Wort and Major Depression. JAMA. 2001;286(1):42-45. doi:10.1001/jama.286.1.42